EDGAR Filing Documents for 0001193805-21-000519

Form 8-K - Current report:

SEC Accession No. 0001193805-21-000519

Filing Date

2021-04-21

Accepted

2021-04-21 08:14:21

Documents

Period of Report

2021-04-20

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8k12566001_04162021.htm	8-K	28160
2		ex41to8k12566001_04162021.htm	EX-4.1	33279
3		ex51to8k12566001_04162021.htm	EX-5.1	10061
4		ex101to8k12566001_04162021.htm	EX-10.1	109876
5		ex102to8k12566001_04162021.htm	EX-10.2	32089
6		ex103to8k12566001_04162021.htm	EX-10.3	9974
7		ex232to8k12566001_04162021.htm	EX-23.2	10064
8		ex991to8k12566001_04162021.htm	EX-99.1	33866
9		ex992to8k12566001_04162021.htm	EX-99.2	17479
10		ex993to8k12566001_04162021.htm	EX-99.3	18113
11		ex994to8k12566001_04162021.htm	EX-99.4	14208
12		ex995to8k12566001_04162021.htm	EX-99.5	19148
13		ex996to8k12566001_04162021.htm	EX-99.6	24184
14		ex997to8k12566001_04162021.htm	EX-99.7	10191
15	GRAPHIC	image_001.jpg	GRAPHIC	4299
	Complete submission text file	0001193805-21-000519.txt		378300

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142

Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149

Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)